GGrantIndex
Sort

53,477 grants matching addiction

CATEGORICAL DECISION-MAKING IN FRONTO-STRIATAL CIRCUITS

$382,536
Vincent P Ferrera · Columbia University Health Sciences · R01 · FY2013 · MH

Reward, Impulsivity and Cocaine Addiction; fMRI Studies

$382,517
Godfrey D Pearlson · Yale University · R01 · FY2008 · DA

Calcium-related Neurotoxicity of Cocaine

$382,501
Congwu Du · State University New York Stony Brook · R01 · FY2017 · DA

Reconsolidation and extinction processes in the treatment of drug addiction

$382,500
Yossef Itzhak · University Of Miami School Of Medicine · R01 · FY2010 · DA

Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier

$382,500
Thomas J Abbruscato · Texas Tech University Health Scis Center · R01 · FY2020 · DA

Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier

$382,500
Thomas J Abbruscato · Texas Tech University Health Scis Center · R01 · FY2021 · DA

Nonhuman Primate Model of Cocaine Relapse and Treatment

$382,500
Harvard University (Medical School) · R01 · FY2004 · DA

Nonhuman Primate Model of Cocaine Relapse and Treatment

$382,500
Harvard University (Medical School) · R01 · FY2005 · DA

Nonhuman Primate Model of Cocaine Relapse and Treatment

$382,500
Harvard University (Medical School) · R01 · FY2003 · DA

CNS Mechanisms in Cocaine-Related Sudden Death

$382,500
Deborah C. Mash · University Of Miami School Of Medicine · R01 · FY2009 · DA

Nonhuman Primate Model of Cocaine Relapse and Treatment

$382,500
Harvard University (Medical School) · R01 · FY2002 · DA

Molecular Determinants of Compulsive Cocaine-Taking

$382,500
University Of Cincinnati · R01 · FY2001 · DA

Nonhuman Primate Model of Cocaine Relapse and Treatment

$382,500
Harvard University (Medical School) · R01 · FY2001 · DA

Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier

$382,500
Luca Cucullo · Texas Tech University Health Scis Center · R01 · FY2019 · DA

Validation of FGF14 as a New Molecular Target of GSK3

$382,500
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2012 · MH

Validation of FGF14 as a New Molecular Target of GSK3

$382,500
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2014 · MH

The Molecular Basis of Alcohol's Actions

$382,500
David Nigel Jones · University Of Colorado Denver · R01 · FY2010 · AA

Validation of FGF14 as a New Molecular Target of GSK3

$382,500
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2016 · MH

Validation of FGF14 as a New Molecular Target of GSK3

$382,500
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2015 · MH

Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters

$382,486
Subramaniam Ananthan · Southern Research Institute · R21 · FY2010 · DA

Ctr9 as a Predictive Biomarker for EZH2 Inhibitor Sensitivity

$382,472
Wei Xu · University Of Wisconsin-Madison · R01 · FY2024 · CA

Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity

$382,471
Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Amygdala-cortical circuitry in reward encoding, expectation, and decision making

$382,420
Kate Wassum · University Of California Los Angeles · R01 · FY2020 · DA

Sex Differences in Drug Effects: The Adolescent Trajectory

$382,402
Emmalee S. Bandstra · University Of Miami School Of Medicine · P50 · FY2011 · DA

Genetic Control of Basal Telencephalic Development

$382,388
John L. R. Rubenstein · University Of California, San Francisco · R01 · FY2012 · MH